S&P 500   3,375.11 (+0.44%)
DOW   28,030.00 (+0.86%)
QQQ   270.24 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
S&P 500   3,375.11 (+0.44%)
DOW   28,030.00 (+0.86%)
QQQ   270.24 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
S&P 500   3,375.11 (+0.44%)
DOW   28,030.00 (+0.86%)
QQQ   270.24 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
S&P 500   3,375.11 (+0.44%)
DOW   28,030.00 (+0.86%)
QQQ   270.24 (-0.03%)
AAPL   446.06 (-1.08%)
MSFT   207.45 (-0.38%)
FB   265.28 (+0.87%)
GOOGL   1,509.66 (+0.86%)
AMZN   3,152.66 (+0.14%)
NVDA   442.32 (-0.96%)
CGC   17.70 (-1.28%)
BABA   251.72 (+1.45%)
TSLA   1,412.49 (-0.43%)
GE   6.81 (+1.95%)
MU   48.84 (-0.63%)
AMD   79.05 (-3.88%)
T   30.36 (+0.53%)
F   7.28 (+2.68%)
ACB   10.10 (-1.17%)
GILD   68.30 (-0.31%)
NFLX   476.08 (-1.51%)
DIS   131.26 (+1.92%)
BAC   27.40 (+3.16%)
BA   185.20 (+3.23%)
Log in

NYSE:DAVAEndava Stock Price, Forecast & News

$51.50
-1.29 (-2.44 %)
(As of 08/11/2020 12:46 PM ET)
Add
Compare
Today's Range
$51.35
Now: $51.50
$52.83
50-Day Range
$47.40
MA: $51.32
$54.55
52-Week Range
$27.21
Now: $51.50
$56.76
Volume1,413 shs
Average Volume131,149 shs
Market Capitalization$2.73 billion
P/E Ratio99.04
Dividend YieldN/A
Beta1.2
Endava plc provides technology services for clients in the consumer products, healthcare, logistics, and retail verticals in Europe, Latin America, and the United States. It offers strategy, creative and user experience, insights through data, mobile and Internet of Things, architecture, smart automation, software engineering, test automation and engineering, continuous delivery, cloud, applications management, and smart desk services across the digital evolution, agile transformation, and automation solution areas. The company was founded in 2000 and is headquartered in London, United Kingdom.
Read More
Endava logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.2Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry Custom computer programming services
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone44-20-7367-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$374.45 million
Cash Flow$1.18 per share
Book Value$4.06 per share

Profitability

Net Income$31.07 million

Miscellaneous

Employees5,754
Market Cap$2.73 billion
Next Earnings Date9/23/2020 (Estimated)
OptionableNot Optionable
$51.50
-1.29 (-2.44 %)
(As of 08/11/2020 12:46 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DAVA News and Ratings via Email

Sign-up to receive the latest news and ratings for DAVA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Endava (NYSE:DAVA) Frequently Asked Questions

How has Endava's stock been impacted by Coronavirus (COVID-19)?

Endava's stock was trading at $43.43 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DAVA stock has increased by 18.6% and is now trading at $51.50.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Endava?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Endava in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Endava
.

When is Endava's next earnings date?

Endava is scheduled to release its next quarterly earnings announcement on Wednesday, September 23rd 2020.
View our earnings forecast for Endava
.

How were Endava's earnings last quarter?

Endava PLC - (NYSE:DAVA) posted its quarterly earnings results on Thursday, May, 21st. The company reported $0.23 EPS for the quarter, topping the Zacks' consensus estimate of $0.22 by $0.01. The business earned $92.20 million during the quarter, compared to analysts' expectations of $87.64 million. Endava had a return on equity of 13.83% and a net margin of 6.85%. The company's revenue for the quarter was up 25.8% on a year-over-year basis. During the same period last year, the firm earned $0.19 EPS.
View Endava's earnings history
.

What guidance has Endava issued on next quarter's earnings?

Endava updated its fourth quarter 2020 IntraDay earnings guidance on Thursday, May, 21st. The company provided earnings per share guidance of 0.19-0.21 for the period. The company issued revenue guidance of $110.166-111.447 million.

What price target have analysts set for DAVA?

7 brokers have issued 1-year price targets for Endava's stock. Their forecasts range from $43.00 to $60.00. On average, they anticipate Endava's stock price to reach $53.71 in the next year. This suggests a possible upside of 4.3% from the stock's current price.
View analysts' price targets for Endava
.

Has Endava been receiving favorable news coverage?

Media headlines about DAVA stock have been trending neutral recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Endava earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
View the latest news about Endava
.

Are investors shorting Endava?

Endava saw a decrease in short interest in February. As of February 15th, there was short interest totaling 47,900 shares, a decrease of 17.0% from the January 31st total of 57,700 shares. Based on an average trading volume of 115,700 shares, the short-interest ratio is currently 0.4 days.
View Endava's Short Interest
.

Who are some of Endava's key competitors?

What other stocks do shareholders of Endava own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Endava investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Taiwan Semiconductor Mfg. (TSM), Splunk (SPLK), Zscaler (ZS), Advanced Micro Devices (AMD), Walt Disney (DIS), Mastercard (MA) and Paypal (PYPL).

Who are Endava's key executives?

Endava's management team includes the following people:
  • Mr. John E. Cotterell, CEO & Director (Age 58)
  • Mr. Peter M. Stroeve, Managing Partner
  • Mr. Mark S. Thurston, CFO & Director (Age 55)
  • Mr. Rob Machin, Chief Operating Officer (Age 46)
  • Ms. Laurence Madsen, Investor Relations Mang.

When did Endava IPO?

(DAVA) raised $101 million in an IPO on Friday, July 27th 2018. The company issued 5,600,000 shares at a price of $17.00-$19.00 per share. Morgan Stanley, Citigroup, Credit Suisse and Deutsche Bank Securities acted as the underwriters for the IPO and Cowen and William Blair were co-managers.

What is Endava's stock symbol?

Endava trades on the New York Stock Exchange (NYSE) under the ticker symbol "DAVA."

Who are Endava's major shareholders?

Endava's stock is owned by many different institutional and retail investors. Top institutional shareholders include KAMES CAPITAL plc (0.22%), Summit Creek Advisors LLC (0.18%), Baystate Wealth Management LLC (0.17%), Kornitzer Capital Management Inc. KS (0.17%), Russell Investments Group Ltd. (0.15%) and Raymond James & Associates (0.05%).

Which major investors are selling Endava stock?

DAVA stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., KAMES CAPITAL plc, Pendal Group Ltd, and Kornitzer Capital Management Inc. KS.

Which major investors are buying Endava stock?

DAVA stock was purchased by a variety of institutional investors in the last quarter, including Baystate Wealth Management LLC, Raymond James & Associates, Essex Investment Management Co. LLC, Summit Creek Advisors LLC, Trexquant Investment LP, First Trust Advisors LP, PNC Financial Services Group Inc., and UBS Group AG.

How do I buy shares of Endava?

Shares of DAVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Endava's stock price today?

One share of DAVA stock can currently be purchased for approximately $51.50.

How big of a company is Endava?

Endava has a market capitalization of $2.73 billion and generates $374.45 million in revenue each year. The company earns $31.07 million in net income (profit) each year or $0.99 on an earnings per share basis. Endava employs 5,754 workers across the globe.

What is Endava's official website?

The official website for Endava is www.endava.com.

How can I contact Endava?

Endava's mailing address is 125 OLD BROAD STREET, LONDON X0, EC2N 1AR. The company can be reached via phone at 44-20-7367-1000.

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.